These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4468 related articles for article (PubMed ID: 5014573)
1. Defibrination and metastasis formation: effects of arvin on experimental metastases in mice. Hagmar B Eur J Cancer (1965); 1972 Feb; 8(1):17-28. PubMed ID: 5014573 [No Abstract] [Full Text] [Related]
2. The effect of arvin on blood coagulation factors. Bell WR; Bolton G; Pitney WR Br J Haematol; 1968 Dec; 15(6):589-602. PubMed ID: 5710065 [No Abstract] [Full Text] [Related]
3. Proceedings: Inhibition of experimental metastases by defibrination. Jagelman DG Ann R Coll Surg Engl; 1974 Jun; 54(6):271. PubMed ID: 4833776 [No Abstract] [Full Text] [Related]
4. Effects of Ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity. Silberman S; Bernik MB; Potter EV; Kwaan HC Br J Haematol; 1973 Jan; 24(1):101-13. PubMed ID: 4197581 [No Abstract] [Full Text] [Related]
5. Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation. McCulloch P; George WD Br J Cancer; 1988 Aug; 58(2):158-62. PubMed ID: 3166906 [TBL] [Abstract][Full Text] [Related]
6. The effect of a fibrinolytic agent (Arvin) on wound healing and collagen formation. Holt PJ; Holloway V; Raghupati N; Calnan JS Clin Sci; 1970 Feb; 38(2):9P. PubMed ID: 5416161 [No Abstract] [Full Text] [Related]
7. Interaction of Arvin with erythrocyte flexibility. Myers P; Rampling MW; Sirs JA J Physiol; 1973 Apr; 230(1):51P-52P. PubMed ID: 4702445 [No Abstract] [Full Text] [Related]
8. The effect of arvin on plasma lipids of the rabbit. Barboriak JJ Proc Soc Exp Biol Med; 1971 Jan; 136(1):313-5. PubMed ID: 5540632 [No Abstract] [Full Text] [Related]
9. [Arvin anticoagulant for prolonged extracorporeal membrane oxygenation (author's transl)]. White JJ; Bell W; Matthews P; Büky B Anaesthesist; 1976 Nov; 25(11):526-8. PubMed ID: 1008240 [TBL] [Abstract][Full Text] [Related]
10. Mononuclear phagocytes in the control of primary and secondary tumor growth. Keller R Adv Exp Med Biol; 1982; 155():289-302. PubMed ID: 7158486 [TBL] [Abstract][Full Text] [Related]
11. The effect of Arvin on reticuloendothelial activity in rabbits. Ashford A; Bunn DR Br J Pharmacol; 1970 Sep; 40(1):37-44. PubMed ID: 5487022 [TBL] [Abstract][Full Text] [Related]
12. A new therapeutic anticoagulant. Archer RK; Close M; Ashford A Vet Rec; 1969 Feb; 84(6):150-1. PubMed ID: 5770629 [No Abstract] [Full Text] [Related]
13. Blood flow in transplanted tumors: quantitative approaches to radioisotopic studies. Spencer RP Yale J Biol Med; 1970 Aug; 43(1):22-30. PubMed ID: 4319305 [No Abstract] [Full Text] [Related]
14. [Distribution and development of experimental metastasis after treatment with anticoagulants]. Boeryd B; Hagmar B Nord Med; 1970 Nov; 84(45):1439-40. PubMed ID: 5481052 [No Abstract] [Full Text] [Related]
15. Effects of arvin on blood platelets. In vitro and in vivo studies. Brown CH; Bell WR; Shreiner DP; Jackson DP J Lab Clin Med; 1972 May; 79(5):758-69. PubMed ID: 5018740 [No Abstract] [Full Text] [Related]
16. Changes in platelet behaviour during arvin therapy. Prentice CR; Turpie AG; Hassanein AA; McNicol GP; Douglas AS Lancet; 1969 Mar; 1(7596):645-7. PubMed ID: 4179884 [No Abstract] [Full Text] [Related]
17. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Cifone MA; Fidler IJ Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6949-52. PubMed ID: 6947269 [TBL] [Abstract][Full Text] [Related]
18. Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine model. Seth R; Tai LH; Falls T; de Souza CT; Bell JC; Carrier M; Atkins H; Boushey R; Auer RA Ann Surg; 2013 Jul; 258(1):158-68. PubMed ID: 23108132 [TBL] [Abstract][Full Text] [Related]
19. The pattern of tumour growth. Bullough WS; Deol JU Symp Soc Exp Biol; 1971; 25():255-75. PubMed ID: 4256515 [No Abstract] [Full Text] [Related]
20. The paradox in therapeutic defibrination. Reid HA; Chan KE Lancet; 1968 Mar; 1(7541):485-6. PubMed ID: 4171199 [No Abstract] [Full Text] [Related] [Next] [New Search]